Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
Giovanni MarascoMarcello MaidaCesare CremonMaria Raffaella BarbaroVincenzo StanghelliniGiovanni BarbaraPublished in: Alimentary pharmacology & therapeutics (2023)
COVID-19 survivors were found to be at risk for IBS development compared to controls. No definitive data are available for FD.